Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer

Jacqueline Vuky, Elizabeth R. Plimack, Peter H. O’Donnell et al.|Journal of Clinical Oncology|2020

Cited by 292